Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors

ClinicalTrials.gov ID: NCT02289560

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02289560. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Continued Access Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this prospective, multi site, single-arm study is to capture the efficacy of treatment using the ExAblate Transcranial System and to further demonstrate safety in medication-refractory tremor in patients with essential tremor (ET).

Study identification

NCT ID: NCT02289560
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: InSightec; Industry
Enrollment: 61 participants

Conditions and interventions

Conditions

Essential Tremor

Interventions

Transcranial ExAblate Device

Device

Eligibility (public fields only)

Age range: 22 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2015 (Actual)
Primary completion: Feb 18, 2022 (Actual)
Completion: Mar 10, 2023 (Actual)
Last update posted: Jul 3, 2024

2015 – 2023

United States locations

U.S. sites: 7
U.S. states: 7
U.S. cities: 7

Facility	City	State	ZIP	Site status
Stanford University Medical Center	Stanford	California	94305	—
University of Maryland Medical System	Baltimore	Maryland	21201	—
Brigham and Women's Hospital	Boston	Massachusetts	02115	—
The Ohio State Wexner Medical Center	Columbus	Ohio	43210	—
University of Pennsylvania	Philadelphia	Pennsylvania	19106	—
University of Virginia	Charlottesville	Virginia	22908	—
Swedish Medical Center	Seattle	Washington	98122	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02289560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 3, 2024 · Synced Nov 15, 2026